| 000 | 01130cam a2200313 4500 | ||
|---|---|---|---|
| 999 |
_c44004 _d44004 |
||
| 001 | 44004 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102105605.0 | ||
| 008 | 990406c1995 us d w 00011 eng s | ||
| 035 | _aSirsi) i9780841229204 | ||
| 040 |
_aUSA.FAR _dES-MaUEC |
||
| 050 | 4 |
_aRS431.A64 _bC36 1995 |
|
| 245 | 0 | 0 |
_aCancer chemotherapeutic agents _cWilliam O. Foye, editor |
| 260 |
_aWashington _bAmerican Chemical Society _c1995 |
||
| 300 |
_a698 páginas _bgráficos _c26 cm |
||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_asin mediación _bn _2rdamedia |
||
| 338 |
_avolumen _bnc _2rdacarrier |
||
| 490 | 0 | _aACS professional reference book | |
| 650 | 0 | 7 |
_aAntineoplásicos _xUso terapeútico _9405304 _2embne |
| 650 | 0 | 7 |
_aCáncer _9139308 _2embne |
| 700 | 1 |
_aFoye, William O. _eeditor literario _912314 _0comprobar BNE19900263348 |
|
| 901 | _ai0841229201 | ||
| 907 |
_a.b10508508 _b10-11-17 _c06-01-12 |
||
| 907 | 0 | 0 | _a011RA |
| 942 |
_2lcc _cM1S |
||
| 945 |
_aRS431 .A64 C36 1995 _g1 _i9300372820 _j0 _lmcg _o- _pEUR0.00 _q- _r- _s- _t1 _u2 _v0 _w0 _x0 _y.i10678293 _z06-01-12 |
||
| 998 |
_am _a_vill _b05-01-12 _cm _da _e- _feng _gxxu _h0 |
||